Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Kroboth

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|June 1, 1991
Comparison of adinazolam pharmacokinetics and effects in healthy and cirrhotic subjectsP D Kroboth, R A Maxwell, J C Fleishaker, et al.
Fertility and Sterility|September 1, 1986
Single-dose pharmacokinetics of clomiphene citrate in normal volunteersT J Mikkelson, P D Kroboth, W J Cameron, et al.
Journal of Clinical Pharmacology|May 20, 1998
Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course?P D Kroboth, M M Folan, K S Bauer, et al.
Critical Care Medicine|May 30, 2001
Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patientsM M Folan, R A Stone, A L Pittenger, et al.
Clinical Pharmacology and Therapeutics|November 1, 1984
Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kineticsG P Stoehr, P D Kroboth, R P Juhl, et al.
Journal of Psychiatric Research|June 3, 2008
Dysregulation of neurosteroids in obsessive compulsive disorderK L Bigos, M M Folan, M R Jones, et al.
Journal of Clinical Psychopharmacology|June 1, 1995
Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight menC L Derry, P D Kroboth, A L Pittenger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1997
Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patientsJ A Sweeney, K S Bauer, M S Keshavan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of end-stage renal disease and aluminum hydroxide on temazepam kineticsP D Kroboth, R B Smith, R Rault, et al.
Clinical Pharmacology and Therapeutics|September 1, 1984
Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentrationP D Kroboth, R B Smith, M I Sorkin, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|June 1, 1991
Comparison of adinazolam pharmacokinetics and effects in healthy and cirrhotic subjectsP D Kroboth, R A Maxwell, J C Fleishaker, et al.
Fertility and Sterility|September 1, 1986
Single-dose pharmacokinetics of clomiphene citrate in normal volunteersT J Mikkelson, P D Kroboth, W J Cameron, et al.
Journal of Clinical Pharmacology|May 20, 1998
Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course?P D Kroboth, M M Folan, K S Bauer, et al.
Critical Care Medicine|May 30, 2001
Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patientsM M Folan, R A Stone, A L Pittenger, et al.
Clinical Pharmacology and Therapeutics|November 1, 1984
Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kineticsG P Stoehr, P D Kroboth, R P Juhl, et al.
Journal of Psychiatric Research|June 3, 2008
Dysregulation of neurosteroids in obsessive compulsive disorderK L Bigos, M M Folan, M R Jones, et al.
Journal of Clinical Psychopharmacology|June 1, 1995
Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight menC L Derry, P D Kroboth, A L Pittenger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 1, 1997
Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patientsJ A Sweeney, K S Bauer, M S Keshavan, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of end-stage renal disease and aluminum hydroxide on temazepam kineticsP D Kroboth, R B Smith, R Rault, et al.
Clinical Pharmacology and Therapeutics|September 1, 1984
Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentrationP D Kroboth, R B Smith, M I Sorkin, et al.
Pageof 6